Medical News

RSS

VAP Cholesterol Test can evaluate Polycystic Ovarian Syndrome

Polycystic Ovarian Syndrome, known as PCOS, is a silent and often mysterious disease that plays havoc with a woman's body and increases the risk of serious illness. There is no single test for diagnosing the illness, but a detailed cholesterol profile called the VAP Cholesterol Test, along with diet, exercise and the right medication, is changing how doctors approach PCOS and is dramatically altering patients' lives for the better.

10 Sep 2010

WebMD announces results of tender offer to purchase 3,000,000 shares of common stock

WebMD Health Corp. announced today the preliminary results of its tender offer to purchase up to 3,000,000 shares of its common stock at a price of $52.00 per share, which expired at 5:00 p.m., New York City time, on September 8, 2010.

10 Sep 2010

Edimer Pharmaceuticals, CMC Biologics execute manufacturing contract to develop EDI200 recombinant protein

Edimer Pharmaceuticals and CMC Biologics today announce the execution of a manufacturing contract to support the development of EDI200, a clinical-stage recombinant protein for the treatment of X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), a rare genetic disease with orphan designation in the USA and Europe.

10 Sep 2010

Researchers to develop two-way fiber optic communication between prosthetic limbs and peripheral nerves

Lightning fast connections between robotic limbs and the human brain may be within reach for injured soldiers and other amputees with the establishment of a multimillion-dollar research center led by SMU engineers.

10 Sep 2010

UK researchers discover new tactic used by cancer cells to cheat death

Cancer Research UK scientists have uncovered a new strategy that could be used by cancer cells to side step the body's normal safety checks and become immortal a key step for a cancer cell according to a study published in Nature today (Thursday).

10 Sep 2010

ECRI Institute PSO launches Patient Safety E-lerts to reduce healthcare events' risk

In response to adverse event reports received by ECRI Institute PSO and to promote such learning, ECRI Institute PSO has begun disseminating periodic Patient Safety E-lerts to participating organizations. The Patient Safety E-lert will bring attention to these issues and is concisely formatted to stimulate discussion and action by interdisciplinary committees focused on reducing the risk of healthcare events.

10 Sep 2010

FDA approves Abreu BTT 700 System for temperature monitoring

Brain Tunnelgenix Technologies Corp. announced today that the U.S. Food and Drug Administration (FDA) has granted the company clearance to market its Abreu BTT 700 System for continuous temperature monitoring.

10 Sep 2010

PracticeMax acquires Medinomics, expands healthcare and technology expertise

PracticeMax, a provider of revenue cycle management and software services, today announced it has acquired Medinomics, of Shreveport, La., expanding the operations and geographical footprint of PracticeMax throughout the southern United States.

10 Sep 2010

Halozyme Therapeutics announces public offering of 8.3 million shares of common stock

Halozyme Therapeutics, Inc. today announced the pricing of its previously announced public offering of 8.3 million shares of its common stock at a price to the public of $7.50 per share.

10 Sep 2010

Oxygen Biotherapeutics 2010 first quarter net loss increases to $3 million

Oxygen Biotherapeutics, Inc., a development stage biomedical company focused on developing oxygen-rich intravenous and topical products, today announced results for the fiscal year (FY) first quarter ended July 31, 2010.

10 Sep 2010

Canberra restaurants put on notice over hygiene

According to health authorities some of the ‘shabbier’ Canberra restaurants have been put on notice after a court quadrupled the fines imposed on an inner north eatery caught preparing food in “Third World” conditions.

9 Sep 2010

56% of Australians won’t vaccinate against Swine flu: Survey

Over fifty per cent of Australians were not vaccinated against the swine flu before winter arrived this year, with many of these people deliberately choosing not to be vaccinated.

9 Sep 2010

Safe sex campaign for over 50’s

New figures have shown an alarming rise in sexually transmitted infections among the over-50s in Britain. Health charity FPA (Flamily Planning Association) has come up with a nation wide campaign using fashion adverts from the 60s and 70s to encourage members of the baby boomer generation to use condoms and practice safe sex.

9 Sep 2010

Obesity key lies in the brain: Study

According to a new international study led in Australia by the Monash Obesity and Diabetes Institute (MODI) at Monash University, high fat diets that lead to obesity and weight gain make the brain immune to signals that tell the body to stop eating and to burn energy.

9 Sep 2010

New melanoma drug in the pipeline from Plexxikon and Roche

Researchers from biotech company Plexxikon have found that their candidate drug for skin cancer melanomas can be administered more effectively in early stages of the disease.

9 Sep 2010

National Dementia Awareness Week

This National Dementia Awareness Week 15-22 September, Alzheimer’s Australia and National Dementia Awareness Week Ambassador, Dr Andrew Rochford will be promoting the benefit of early diagnosis and where worried friends and family can access help.

9 Sep 2010

Microvisk secures £2.5 million to develop world’s first medical diagnostic SmartStrip®

Microvisk Technologies, the developer of a handheld system to monitor the blood clotting status of patients taking the drug Warfarin, has raised £2.5 million through a rights issue to existing investors. The round was significantly oversubscribed and completed within four weeks.

9 Sep 2010

NovaSterilis issued US patent

NovaSterilis Inc. has been issued US Patent # 7,771,652 B2 for “Combined Use of an Alkaline Earth Metal Compound and a Sterilizing Agent to Maintain Osteoinduction Properties of a Demineralized Bone Matrix”

9 Sep 2010

Roche announces Ambry Genetics as first US CSP for NimbleGen SeqCap EZ Exome workflow

Roche NimbleGen announces that Southern California (Aliso Viejo) based genomic services provider Ambry Genetics has officially become a Certified Service Provider (CSP) for the NimbleGen SeqCap EZ Exome workflow. They will provide target-enrichment services using NimbleGen SeqCap EZ Human Exome coupled with next-generation sequencing services for genetic research.

9 Sep 2010

Affinity Health System selects GE Centricity EMR for patient care network

Northeast Wisconsin's nationally recognized Affinity Health System is the latest to choose GE Centricity® EMR for its patient care network. The Catholic, mission-oriented, regional health network is a collaboration between the Fox Valley's Ministry Health Care and Wheaton Franciscan Healthcare and plans to implement Centricity EMR across its 22 multi-specialty clinics in 14 communities to help care for an average of 21,000 patients each year.

9 Sep 2010